Alkyl sulfoxide quinolines as NK-3 receptor ligands

Details for Australian Patent Application No. 2006292849 (hide)

Owner AstraZeneca AB

Inventors Alhambra, Cristobal; Koether, Gerard M.; Kang, James; Albert, Jeffrey S.; Simpson, Thomas R.; Woods, James; Li, Yan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006292849

PCT Pub. Number WO2007/035158

Priority 60/719,286 21.09.05 US; 60/719,275 21.09.05 US

Filing date 19 September 2006

Wipo publication date 29 March 2007

International Classifications

C07D 215/52 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/035158 Priority application(s): WO2007/035158

18 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006292850-An engine arrangement

2006292846-A foil winding pulse transformer